Document
IPR2018-00293, No. 2053-98 Exhibit - Brauer, J Clin Pharm 16 1, 72 76 1996 (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00293, No. 2053-98 Exhibit - Brauer, J Clin Pharm 16 1, 72 76 1996 (P.T.A.B. Apr. 10, 2018)
+ More Snippets
Document
IPR2018-00293, No. 2004-47 Exhibit - MYDAYIS¿¿ FDA Label 06 2017 (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00293, No. 2004-47 Exhibit - MYDAYIS¿¿ FDA Label 06 2017 (P.T.A.B. Apr. 10, 2018)
+ More Snippets
Document
IPR2018-00293, No. 2029-74 Exhibit - Winters, Basic Clinical Pharmacokinetics 1994 (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00293, No. 2029-74 Exhibit - Winters, Basic Clinical Pharmacokinetics 1994 (P.T.A.B. Apr. 10, 2018)
+ More Snippets
Document
IPR2018-00293, No. 2035-80 Exhibit - Macheras, Oral Drug Absorption, Ch 6 Modeling Biopharm 2006 (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00293, No. 2035-80 Exhibit - Macheras, Oral Drug Absorption, Ch 6 Modeling Biopharm 2006 (P.T.A.B. Apr. 10, 2018)
+ More Snippets
Document
IPR2018-00293, No. 2034-79 Exhibit - Gupta and Robinson, Controlled Release Delivery 1992 (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00293, No. 2034-79 Exhibit - Gupta and Robinson, Controlled Release Delivery 1992 (P.T.A.B. Apr. 10, 2018)
+ More Snippets
Document
IPR2018-00293, No. 2045-90 Exhibit - Swanson, Clin Pharmacol Therap, 66 95 305 1999 (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00293, No. 2045-90 Exhibit - Swanson, Clin Pharmacol Therap, 66 95 305 1999 (P.T.A.B. Apr. 10, 2018)
+ More Snippets
Document
IPR2018-00293, No. 2031-76 Exhibit - Mircioiu, Basic Clinical Pharmacology Toxicology, 96 262¿¿¿264 2005 (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00293, No. 2031-76 Exhibit - Mircioiu, Basic Clinical Pharmacology Toxicology, 96 262¿¿¿264 2005 (P.T.A.B. Apr. 10, 2018)
+ More Snippets
Document
IPR2018-00293, No. 2011-55 Exhibit - Sonsalia, Remington Ch 74, CNS Stimulants 1995 (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00293, No. 2011-55 Exhibit - Sonsalia, Remington Ch 74, CNS Stimulants 1995 (P.T.A.B. Apr. 10, 2018)
+ More Snippets
Document
IPR2018-00293, No. 2057-100 Exhibit - Protective Order (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00293, No. 2057-100 Exhibit - Protective Order (P.T.A.B. Apr. 10, 2018)
+ More Snippets
Document
IPR2018-00293, No. 1041-42 Exhibit - 1041 Declaration of Chad Landmon in support of Pro Hac Vice (P.T.A.B. Jan. 9, 2018)
Cite Document
IPR2018-00293, No. 1041-42 Exhibit - 1041 Declaration of Chad Landmon in support of Pro Hac Vice (P.T.A.B. Jan. 9, 2018)
+ More Snippets
Document
IPR2018-00293, No. 1017-18 Exhibit - 1017 US Patent No 8,313,776 (P.T.A.B. Dec. 11, 2017)
Cite Document
IPR2018-00293, No. 1017-18 Exhibit - 1017 US Patent No 8,313,776 (P.T.A.B. Dec. 11, 2017)
+ More Snippets
Document
IPR2018-00293, No. 1028-29 Exhibit - 1028 HPE 2d ed 1994 (P.T.A.B. Dec. 11, 2017)
Cite Document
IPR2018-00293, No. 1028-29 Exhibit - 1028 HPE 2d ed 1994 (P.T.A.B. Dec. 11, 2017)
+ More Snippets
Document
IPR2018-00293, No. 1040-41 Exhibit - 1040 Fallingborg 1990 (P.T.A.B. Dec. 11, 2017)
Cite Document
IPR2018-00293, No. 1040-41 Exhibit - 1040 Fallingborg 1990 (P.T.A.B. Dec. 11, 2017)
+ More Snippets
Document
IPR2018-00293, No. 1002-2 Exhibit - 1002 US 6,605,300 (P.T.A.B. Dec. 11, 2017)
Cite Document
IPR2018-00293, No. 1002-2 Exhibit - 1002 US 6,605,300 (P.T.A.B. Dec. 11, 2017)
+ More Snippets
Document
IPR2018-00293, No. 1021-22 Exhibit - 1021 Orange Book Approved Drug Products Adderall XR (P.T.A.B. Dec. 11, 2017)
Cite Document
IPR2018-00293, No. 1021-22 Exhibit - 1021 Orange Book Approved Drug Products Adderall XR (P.T.A.B. Dec. 11, 2017)
+ More Snippets